APC rs121908873: What Your Genotype Means
The rs121908873 variant, also known as p.Ile1307Lys or I1307K, is a specific genetic change in the APC gene. It is associated with a moderately increased lifetime risk of developing colorectal cancer, particularly in individuals of Ashkenazi Jewish ancestry.
What each genotype means
Typical risk profile
This genotype represents the common, non-variant form of the APC gene at this position. It is not associated with the specific increased risk of colorectal neoplasia linked to the I1307K variant. Individuals with this genotype should follow standard population-based colorectal cancer screening guidelines.
Carried by the vast majority of the global population, though the frequency of the alternative allele varies significantly by ancestry.
Increased colorectal cancer risk
This genotype, often referred to as the I1307K variant, creates an oligo-adenine tract in the APC gene that may be prone to replication errors. Research indicates a moderately increased risk for colorectal neoplasia, particularly in individuals of Ashkenazi Jewish ancestry. Clinical guidelines, such as those from the NCCN, often recommend that carriers begin colonoscopy screening at age 40, with follow-up every five years.
Found in approximately 6-10% of individuals of Ashkenazi Jewish ancestry, but is rare in other populations.
Increased colorectal cancer risk
This homozygous genotype carries two copies of the I1307K variant, which is associated with a potential for increased susceptibility to colorectal neoplasia. While data on homozygous carriers are more limited than for heterozygotes, the underlying mechanism of site-specific hypermutability remains a clinical consideration. Individuals with this genotype should consult with a genetic counselor or gastroenterologist to discuss personalized screening and surveillance strategies.
This genotype is very rare, occurring primarily within populations where the A allele is more common, such as those of Ashkenazi Jewish descent.
Understanding the Variant and Its Location
The variant rs121908873 is a single nucleotide polymorphism (SNP) located within the APC gene on chromosome 5. Specifically, this variant involves a change at the DNA level (c.3920T>A) that results in an amino acid substitution in the protein product (p.Ile1307Lys). While many variants in the APC gene are linked to Familial Adenomatous Polyposis (FAP)—a condition characterized by the development of hundreds or thousands of polyps—the I1307K variant is distinct. It does not typically cause the classic, severe polyposis phenotype associated with other pathogenic APC mutations. Instead, it is considered a lower-penetrance variant that may subtly alter the function of the APC protein, potentially creating a environment more conducive to the development of colorectal tumors over a person's lifetime.
The Role of the APC Gene
The APC gene provides instructions for making the adenomatous polyposis coli protein. This protein acts as a tumor suppressor, meaning it helps prevent cells from growing and dividing too rapidly or in an uncontrolled way. A primary function of the APC protein is to regulate the Wnt signaling pathway, which is essential for cell communication and the maintenance of the intestinal lining. By controlling the levels of beta-catenin, the APC protein ensures that cells do not proliferate excessively. When the APC gene is mutated, the resulting protein may lose its ability to effectively regulate these pathways. This loss of control can lead to the accumulation of genetic errors in intestinal cells, which is a critical early step in the formation of colorectal adenomas and, eventually, colorectal cancer.
Research and Evidence Strength
Research into rs121908873 has consistently identified it as a risk factor for colorectal cancer, particularly in Ashkenazi Jewish populations. Studies suggest that carriers of this variant have a roughly two-fold increased risk of developing colorectal cancer compared to non-carriers. However, the evidence strength is categorized as limited regarding its clinical utility for individual diagnosis. Unlike high-penetrance mutations that guarantee disease, this variant acts more like a susceptibility factor. It does not appear to cause the early-onset, high-polyp-count phenotype seen in classic FAP. Because the risk increase is moderate, medical organizations often emphasize that while carriers may benefit from personalized screening schedules, the variant itself is not a definitive predictor of cancer. Current research continues to refine how this variant interacts with other genetic and environmental factors to influence overall cancer risk.
Population Frequency
The rs121908873 variant is notably common in individuals of Ashkenazi Jewish descent, with carrier frequencies typically reported between 6% and 10%. In contrast, the variant is considered rare in most other global populations. This distribution pattern is characteristic of a founder mutation, where the variant became more prevalent within a specific, historically isolated group. Because of this ancestry-specific frequency, genetic screening for this variant is often discussed in the context of Jewish heritage. It is important to note that while the variant is more common in this group, the vast majority of people with this genotype will not develop colorectal cancer. Understanding one's ancestry and family history remains a vital component of interpreting the significance of this genetic finding.
Managing Your Genetic Information
If you have been identified as a carrier of the rs121908873 variant, it is important to approach this information with perspective. This result is not a medical diagnosis of cancer, nor does it mean that cancer is inevitable. Instead, it is a piece of information that may help you and your healthcare provider make informed decisions about your health. You should discuss this finding with a genetic counselor or a gastroenterologist who can provide context based on your personal and family medical history. They may recommend earlier or more frequent colorectal cancer screenings, such as colonoscopies, to ensure early detection of any potential issues. Never make changes to your medical care or screening schedule based solely on a genetic report without consulting a qualified clinician who can interpret the results in the context of your overall health.
How common is this variant?
The rs121908873 variant is common in Ashkenazi Jewish populations, with a carrier frequency of approximately 6-10%, while it remains rare in other ethnic groups.
Frequently asked questions
Does having the APC I1307K variant mean I will get colon cancer?
No, having this variant does not mean you will develop cancer. It is a susceptibility factor that moderately increases your lifetime risk, but most carriers do not develop the disease.
Should I get a colonoscopy if I have this variant?
You should discuss your screening options with a gastroenterologist. They may recommend earlier or more frequent colonoscopies based on your specific genetic result and family history.
Is this the same as Familial Adenomatous Polyposis (FAP)?
No, this variant is distinct from the mutations that cause classic FAP. It does not typically result in the high number of polyps associated with FAP.
Why is this variant more common in Ashkenazi Jews?
This is due to a founder effect, where the variant became more common within the Ashkenazi Jewish population due to historical population patterns and limited genetic diversity in the past.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908873?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29